| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P TPR TRIM33 ZNF609 KAT5 CTCF FOSL2 CHD5 MITF POU2F1 BRD3 ASXL2 ATF2 MEF2A CIC WAC | 2.81e-07 | 739 | 93 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | RLF USF3 KLF10 VEZF1 CTCF FOSL2 SOX30 MITF POU2F1 RREB1 CREB1 ATF2 MEF2A | 1.93e-06 | 560 | 93 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | RLF USF3 KLF10 VEZF1 CTCF FOSL2 SOX30 MITF POU2F1 RREB1 CREB1 ATF2 MEF2A | 2.17e-06 | 566 | 93 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | transcription factor binding | YEATS2 LATS1 KAT5 TCERG1 CTCF ARID2 PCLO HIPK2 TAF4B BSN CREB1 ATF2 MEF2A DCP1A | 9.78e-06 | 753 | 93 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.28e-04 | 4 | 93 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | RLF SP2 USF3 KLF10 VEZF1 CTCF ZNF652 FOSL2 SOX30 MITF POU2F1 CC2D1B RREB1 CREB1 ATF2 MEF2A CIC | 2.53e-04 | 1412 | 93 | 17 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SP2 USF3 KLF10 VEZF1 CTCF ZNF652 FOSL2 ZNF335 SOX30 MITF POU2F1 CC2D1B RREB1 CREB1 ATF2 MEF2A CIC | 3.71e-04 | 1459 | 93 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 5.90e-04 | 8 | 93 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 7.08e-04 | 229 | 93 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 1.37e-03 | 12 | 93 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.56e-03 | 582 | 93 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SP2 KLF10 CTCF ZNF652 FOSL2 ZNF335 SOX30 MITF POU2F1 CC2D1B RREB1 CREB1 ATF2 MEF2A | 1.80e-03 | 1244 | 93 | 14 | GO:0000978 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | RLF KMT2C ZNF609 USF3 KAT5 KLF10 TCERG1 VEZF1 CTCF ARID2 FOSL2 PPP1R12A ZNF335 SOX30 MDC1 MITF HIPK2 POU2F1 BRD3 ASXL2 POGZ TAF4B RREB1 CREB1 ATF2 MEF2A | 2.07e-10 | 1390 | 92 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TPR TRIM33 YEATS2 SP2 KAT5 KLF10 TAF9B ZNF608 TCERG1 CTCF ATF7IP CHD5 SOX30 MITF HIPK2 CC2D1B ASXL2 RREB1 ATF2 MEF2A CIC | 5.44e-09 | 1053 | 92 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TPR TRIM33 YEATS2 SP2 KAT5 KLF10 TAF9B ZNF608 TCERG1 CTCF ATF7IP CHD5 SOX30 MITF HIPK2 POU2F1 CC2D1B ASXL2 RREB1 CREB1 ATF2 MEF2A CIC RCOR2 | 6.77e-09 | 1399 | 92 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TPR TRIM33 YEATS2 SP2 KAT5 KLF10 TAF9B ZNF608 TCERG1 CTCF ATF7IP CHD5 SOX30 MITF HIPK2 POU2F1 CC2D1B ASXL2 RREB1 CREB1 ATF2 MEF2A CIC RCOR2 | 8.22e-09 | 1413 | 92 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RLF TPR YEATS2 KMT2C KAT5 CTCF ATF7IP ARID2 ZNF335 CHD5 MDC1 HIPK2 BRD3 POGZ TAF4B CREB1 ATF2 EMSY WAC | 7.00e-08 | 999 | 92 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | RLF TPR YEATS2 KMT2C KAT5 CTCF ATF7IP ARID2 ZNF335 CHD5 MDC1 HIPK2 BRD3 ATF2 EMSY WAC | 2.00e-06 | 896 | 92 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | RLF TPR YEATS2 KMT2C KAT5 CTCF ATF7IP ARID2 ZNF335 CHD5 HIPK2 BRD3 ATF2 WAC | 4.96e-06 | 741 | 92 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 3.00e-05 | 40 | 92 | 4 | GO:1902275 | |
| GeneOntologyBiologicalProcess | developmental growth | IGSF10 SP2 KMT2C LATS1 RAPH1 SPP1 RBBP6 ARID2 LPA FOSL2 SYT1 CREB1 ATF2 UNC79 | 4.95e-05 | 911 | 92 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | embryo development | YEATS2 SP2 COL18A1 LATS1 KAT5 CTCF RBBP6 ARID2 LPA ZNF335 SEC24B HIPK2 POU2F1 BRD3 ASXL2 FLVCR2 CPLANE1 ATF2 | 5.59e-05 | 1437 | 92 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 5.89e-05 | 3 | 92 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.05e-04 | 242 | 92 | 7 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.05e-04 | 242 | 92 | 7 | GO:1903708 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 1.17e-04 | 4 | 92 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 1.24e-04 | 22 | 92 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.27e-04 | 429 | 92 | 9 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 1.62e-04 | 24 | 92 | 3 | GO:0031445 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 1.95e-04 | 5 | 92 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 2.92e-04 | 6 | 92 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | presynapse organization | 3.19e-04 | 73 | 92 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ZNF609 KAT5 KLF10 ZNF608 SNAP91 SPP1 HLA-DRA ARID2 PPP1R12A ZNF335 VCAN MITF ASXL2 CREB1 | 3.40e-04 | 1095 | 92 | 14 | GO:0060284 |
| GeneOntologyBiologicalProcess | growth | IGSF10 SP2 KMT2C LATS1 TAF9B RAPH1 SPP1 RBBP6 ARID2 LPA FOSL2 SYT1 CREB1 ATF2 UNC79 | 3.53e-04 | 1235 | 92 | 15 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 3.91e-04 | 77 | 92 | 4 | GO:2000144 | |
| GeneOntologyBiologicalProcess | lens induction in camera-type eye | 4.07e-04 | 7 | 92 | 2 | GO:0060235 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ZNF609 KAT5 KLF10 SNAP91 HLA-DRA ARID2 ZNF335 VCAN ASXL2 CREB1 | 4.09e-04 | 614 | 92 | 10 | GO:0010720 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 5.91e-04 | 231 | 92 | 6 | GO:0006352 | |
| GeneOntologyCellularComponent | transcription regulator complex | KAT5 TAF9B ATF7IP ARID2 FOSL2 CHD5 HIPK2 POU2F1 TAF4B CREB1 ATF2 MEF2A RCOR2 DCP1A | 3.76e-07 | 596 | 93 | 14 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | TRIM33 YEATS2 SP2 KAT5 KLF10 TAF9B ARID2 FOSL2 CHD5 SOX30 MITF POU2F1 BRD3 POGZ CREB1 ATF2 MEF2A CIC RCOR2 | 2.32e-05 | 1480 | 93 | 19 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR KMT2C KAT5 TAF9B ARID2 FOSL2 ZNF335 CHD5 HIPK2 U2AF2 POU2F1 ASXL2 TAF4B CREB1 ATF2 RCOR2 WAC | 1.09e-04 | 1377 | 93 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 2.13e-04 | 272 | 93 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 5.39e-04 | 8 | 93 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | nuclear body | EIF2D RAPH1 TCERG1 RBBP6 ATF7IP CHD5 MDC1 HIPK2 U2AF2 RREB1 WAC PAPOLG | 6.54e-04 | 903 | 93 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 8.25e-04 | 94 | 93 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.06e-03 | 45 | 93 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.20e-03 | 104 | 93 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.34e-03 | 107 | 93 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.43e-03 | 109 | 93 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.43e-03 | 109 | 93 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 1.72e-03 | 14 | 93 | 2 | GO:0099569 | |
| HumanPheno | Abnormal nasal tip morphology | TPR COL18A1 KAT5 CTCF ARID2 CHD5 SYT1 ASXL2 POGZ RREB1 CPLANE1 WAC | 7.11e-06 | 386 | 36 | 12 | HP:0000436 |
| Domain | Znf_piccolo | 2.51e-05 | 2 | 94 | 2 | IPR008899 | |
| Domain | zf-piccolo | 2.51e-05 | 2 | 94 | 2 | PF05715 | |
| Domain | ZINC_FINGER_C2H2_2 | RLF SP2 ZNF609 KLF10 ZNF608 VEZF1 CTCF ZNF652 ARID2 ZNF335 ZNF804B POGZ RREB1 ATF2 | 3.19e-05 | 775 | 94 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | RLF SP2 ZNF609 KLF10 ZNF608 VEZF1 CTCF ZNF652 ARID2 ZNF335 ZNF804B POGZ RREB1 ATF2 | 3.28e-05 | 777 | 94 | 14 | PS00028 |
| Domain | Znf_C2H2-like | RLF SP2 ZNF609 KLF10 ZNF608 VEZF1 CTCF ZNF652 ARID2 ZNF335 ZNF804B POGZ RREB1 ATF2 | 4.27e-05 | 796 | 94 | 14 | IPR015880 |
| Domain | SEA | 4.32e-05 | 14 | 94 | 3 | SM00200 | |
| Domain | Znf_C2H2 | RLF SP2 ZNF609 KLF10 ZNF608 VEZF1 CTCF ZNF652 ARID2 ZNF335 ZNF804B POGZ RREB1 ATF2 | 4.83e-05 | 805 | 94 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | RLF SP2 ZNF609 KLF10 ZNF608 VEZF1 CTCF ZNF652 ARID2 ZNF335 ZNF804B POGZ RREB1 ATF2 | 5.02e-05 | 808 | 94 | 14 | SM00355 |
| Domain | SEA | 2.03e-04 | 23 | 94 | 3 | PS50024 | |
| Domain | SEA_dom | 2.03e-04 | 23 | 94 | 3 | IPR000082 | |
| Domain | HMG_box_dom | 3.22e-04 | 65 | 94 | 4 | IPR009071 | |
| Domain | bZIP_1 | 6.60e-04 | 34 | 94 | 3 | PF00170 | |
| Domain | TF_DNA-bd | 8.47e-04 | 37 | 94 | 3 | IPR008917 | |
| Domain | Znf_FYVE_PHD | 8.83e-04 | 147 | 94 | 5 | IPR011011 | |
| Domain | ZF_PHD_2 | 1.35e-03 | 95 | 94 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.40e-03 | 96 | 94 | 4 | PS01359 | |
| Domain | LINK | 1.89e-03 | 13 | 94 | 2 | SM00445 | |
| Domain | Link_dom | 1.89e-03 | 13 | 94 | 2 | IPR000538 | |
| Domain | Xlink | 1.89e-03 | 13 | 94 | 2 | PF00193 | |
| Domain | LINK_1 | 1.89e-03 | 13 | 94 | 2 | PS01241 | |
| Domain | LINK_2 | 1.89e-03 | 13 | 94 | 2 | PS50963 | |
| Domain | BRLZ | 2.28e-03 | 52 | 94 | 3 | SM00338 | |
| Domain | HMG_box | 2.41e-03 | 53 | 94 | 3 | PF00505 | |
| Domain | BZIP | 2.41e-03 | 53 | 94 | 3 | PS50217 | |
| Domain | BZIP_BASIC | 2.41e-03 | 53 | 94 | 3 | PS00036 | |
| Domain | zf-C2H2 | 2.53e-03 | 693 | 94 | 10 | PF00096 | |
| Domain | bZIP | 2.54e-03 | 54 | 94 | 3 | IPR004827 | |
| Domain | HMG | 2.54e-03 | 54 | 94 | 3 | SM00398 | |
| Domain | - | 2.68e-03 | 55 | 94 | 3 | 1.10.30.10 | |
| Domain | RING | 4.42e-03 | 305 | 94 | 6 | SM00184 | |
| Domain | Synaptotagmin | 4.49e-03 | 20 | 94 | 2 | IPR001565 | |
| Domain | SEA | 5.42e-03 | 22 | 94 | 2 | PF01390 | |
| Domain | Znf_RING | 6.08e-03 | 326 | 94 | 6 | IPR001841 | |
| Domain | - | 6.16e-03 | 663 | 94 | 9 | 2.60.40.10 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 7.04e-06 | 301 | 63 | 9 | MM15983 | |
| Pathway | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | 2.39e-05 | 38 | 63 | 4 | M229 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.04e-04 | 55 | 63 | 4 | M39598 | |
| Pathway | PID_ATF2_PATHWAY | 1.37e-04 | 59 | 63 | 4 | M166 | |
| Pubmed | RLF TRIM33 YEATS2 SP2 KMT2C ZNF609 KAT5 KLF10 TAF9B ZNF608 TCERG1 VEZF1 CTCF RBBP6 ATF7IP ARID2 CHD5 MDC1 SEC24B MITF HIPK2 POU2F1 PROSER1 ASXL2 POGZ RREB1 ANKHD1 CREB1 MEF2A CIC EMSY DCP1A FILIP1L | 2.73e-22 | 1429 | 94 | 33 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR TRIM33 YEATS2 ZNF609 TAF9B TCERG1 VEZF1 SNAP91 CTCF RBBP6 ATF7IP ARID2 MDC1 SAP30BP SYT1 U2AF2 POGZ RREB1 CREB1 CIC EMSY WAC | 8.41e-15 | 954 | 94 | 22 | 36373674 |
| Pubmed | Interaction network of human early embryonic transcription factors. | RLF TRIM33 KMT2C ZNF609 KAT5 ZNF608 ARID2 MDC1 MITF POU2F1 PROSER1 ASXL2 POGZ RREB1 EMSY | 3.85e-14 | 351 | 94 | 15 | 38297188 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | YEATS2 SP2 KMT2C ZNF609 KAT5 TAF9B TCERG1 VEZF1 CTCF RBBP6 FOSL2 MDC1 SAP30BP MITF U2AF2 BRD3 ASXL2 POGZ RREB1 CREB1 ATF2 CIC EMSY WAC | 4.85e-14 | 1294 | 94 | 24 | 30804502 |
| Pubmed | TPR YEATS2 KMT2C LATS1 TAF9B RAPH1 TCERG1 RBBP6 ARID2 PPP1R12A MDC1 SEC24B SAP30BP POGZ ANKHD1 EMSY DCP1A | 1.26e-13 | 549 | 94 | 17 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR YEATS2 TBC1D10B EIF2D LATS1 RAPH1 RBBP6 FOSL2 ZNF335 MDC1 POU2F1 BRD3 POGZ RREB1 ATF2 CIC EMSY DCP1A PAPOLG | 2.43e-13 | 774 | 94 | 19 | 15302935 |
| Pubmed | RLF TRIM33 YEATS2 KMT2C ZNF609 TCERG1 VEZF1 ZNF652 ARID2 FOSL2 POU2F1 BIN2 ASXL2 POGZ RREB1 CREB1 ATF2 MEF2A CIC EMSY WAC | 1.47e-12 | 1103 | 94 | 21 | 34189442 | |
| Pubmed | TRIM33 YEATS2 TBC1D10B ZNF609 KAT5 TAF9B ZNF608 CTCF RBBP6 HLA-DRA ARID2 PPP1R12A CHD5 SAP30BP U2AF2 BRD3 POGZ TAF4B RREB1 ANKHD1 RCOR2 | 1.84e-12 | 1116 | 94 | 21 | 31753913 | |
| Pubmed | TRIM33 ZNF609 TAF9B ZNF608 FOSL2 MDC1 CREB1 ATF2 MEF2A CIC EMSY WAC | 9.34e-12 | 268 | 94 | 12 | 33640491 | |
| Pubmed | TRIM33 COL18A1 KMT2C KAT5 TBC1D30 TCERG1 VEZF1 CTCF RBBP6 ZNF652 ARID2 FOSL2 PPP1R12A MDC1 SEC24B SAP30BP BRD3 EIF4G3 ANKHD1 CIC EMSY DDX28 | 6.12e-11 | 1497 | 94 | 22 | 31527615 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TRIM33 YEATS2 SP2 KMT2C ZNF609 ZNF608 VEZF1 ATF7IP ARID2 PCLO BRD3 POGZ RREB1 | 6.19e-11 | 398 | 94 | 13 | 35016035 |
| Pubmed | RLF TPR YEATS2 ZNF609 ZNF608 RAPH1 ATF7IP POGZ RREB1 ANKHD1 CIC RCOR2 DCP1A | 1.13e-10 | 418 | 94 | 13 | 34709266 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR YEATS2 RAPH1 TCERG1 CTCF RBBP6 ATF7IP ARID2 PPP1R12A SEC24B SAP30BP EIF4G3 ANKHD1 CIC EMSY WAC DCP1A | 5.17e-10 | 934 | 94 | 17 | 33916271 |
| Pubmed | TPR KMT2C USF3 LATS1 TCERG1 RBBP6 ATF7IP ARID2 HIPK2 POGZ CPLANE1 CREB1 CIC | 7.12e-10 | 486 | 94 | 13 | 20936779 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR TRIM33 KAT5 TCERG1 FOSL2 PPP1R12A POU2F1 ASXL2 POGZ ANKHD1 CREB1 ATF2 MEF2A CIC EMSY DCP1A | 1.23e-09 | 857 | 94 | 16 | 25609649 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 USF3 LATS1 RBBP6 ARID2 CHD5 MDC1 SAP30BP MITF BSN EIF4G3 CIC | 2.10e-09 | 430 | 94 | 12 | 35044719 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | YEATS2 SP2 USF3 KLF10 CTCF FOSL2 ZNF335 SOX30 MITF POU2F1 RREB1 CREB1 ATF2 MEF2A CIC RCOR2 | 2.80e-09 | 908 | 94 | 16 | 19274049 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | TRIM33 YEATS2 SP2 ZNF609 KLF10 ZNF608 TCERG1 SEC24B MITF EMSY DCP1A PAPOLG | 3.00e-09 | 444 | 94 | 12 | 34795231 |
| Pubmed | MKRN4P SP2 ZNF609 KLF10 VEZF1 CTCF ARID2 FOSL2 POU2F1 BRD3 POGZ ATF2 MEF2A CIC RCOR2 | 4.62e-09 | 808 | 94 | 15 | 20412781 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RLF FSIP2 VEZF1 ARID2 CHD5 MDC1 POU2F1 BRD3 POGZ RREB1 CIC EMSY PAPOLG | 1.04e-08 | 608 | 94 | 13 | 36089195 |
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 10512748 | ||
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 4.91e-08 | 14 | 94 | 4 | 10976766 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 5.16e-08 | 125 | 94 | 7 | 32891193 | |
| Pubmed | MKRN4P RLF SP2 KMT2C VEZF1 FOSL2 POU2F1 BRD3 POGZ ATF2 MEF2A CIC DCP1A | 6.24e-08 | 709 | 94 | 13 | 22988430 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TRIM33 YEATS2 TCERG1 RBBP6 ATF7IP ARID2 HIPK2 BSN CREB1 CIC EMSY PAPOLG | 6.61e-08 | 588 | 94 | 12 | 38580884 |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.84e-07 | 91 | 94 | 6 | 20362542 | |
| Pubmed | TRIM33 KMT2C ZNF609 ZNF608 CHD5 MDC1 NFASC POGZ IGSF1 BSN ANKHD1 | 2.01e-07 | 529 | 94 | 11 | 14621295 | |
| Pubmed | TRIM33 TAF9B RBBP6 ATF7IP PCLO SAP30BP U2AF2 PROSER1 CIC WAC | 2.42e-07 | 425 | 94 | 10 | 24999758 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.06e-06 | 283 | 94 | 8 | 30585729 | |
| Pubmed | TPR COL18A1 KMT2C ZNF652 PPP1R12A VCAN HIPK2 SYT1 BIN2 ASXL2 ANKHD1 CPLANE1 ATF2 DCP1A | 1.29e-06 | 1084 | 94 | 14 | 11544199 | |
| Pubmed | 1.33e-06 | 396 | 94 | 9 | 26687479 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.39e-06 | 203 | 94 | 7 | 22083510 | |
| Pubmed | 1.42e-06 | 399 | 94 | 9 | 35987950 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.80e-06 | 134 | 94 | 6 | 25452129 | |
| Pubmed | 2.19e-06 | 77 | 94 | 5 | 19505873 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.36e-06 | 220 | 94 | 7 | 35785414 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.47e-06 | 150 | 94 | 6 | 28242625 | |
| Pubmed | 5.63e-06 | 251 | 94 | 7 | 31076518 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 6.43e-06 | 167 | 94 | 6 | 20362541 | |
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 16452088 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 7.23e-06 | 2 | 94 | 2 | 23403927 | |
| Pubmed | 12q21 deletion syndrome: Narrowing the critical region down to 1.6 Mb including SYT1 and PPP1R12A. | 7.23e-06 | 2 | 94 | 2 | 32633079 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23076336 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 7.23e-06 | 2 | 94 | 2 | 26793095 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22293360 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20332206 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18776185 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 7.23e-06 | 2 | 94 | 2 | 21935939 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21968021 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 7.23e-06 | 2 | 94 | 2 | 10973822 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25809782 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 27543340 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16896160 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 7.23e-06 | 2 | 94 | 2 | 25652077 | |
| Pubmed | Immunoreactivity of ATF-2 and Fra-2 in human dental follicle. | 7.23e-06 | 2 | 94 | 2 | 20675274 | |
| Pubmed | Identification of a novel, spliced variant of CREB that is preferentially expressed in the thymus. | 7.23e-06 | 2 | 94 | 2 | 9058782 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12958310 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12200150 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 34710701 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 27884605 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 9334251 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 29385729 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 7.23e-06 | 2 | 94 | 2 | 2393399 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11289722 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20573984 | ||
| Pubmed | Tip60 inhibits activation of CREB protein by protein kinase A. | 7.23e-06 | 2 | 94 | 2 | 10720489 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 27321892 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 32493491 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 34348143 | ||
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 7.23e-06 | 2 | 94 | 2 | 10405327 | |
| Pubmed | LATS1 ZNF608 RAPH1 VEZF1 SNAP91 PPP1R12A PCLO CHD5 SAP30BP U2AF2 CC2D1B BRD3 BSN EIF4G3 SPAG17 | 7.31e-06 | 1442 | 94 | 15 | 35575683 | |
| Pubmed | 9.68e-06 | 506 | 94 | 9 | 30890647 | ||
| Pubmed | 1.06e-05 | 106 | 94 | 5 | 19394292 | ||
| Pubmed | TPR AKAP9 SNAP91 CTCF ATF7IP PPP1R12A SYT1 NFASC BSN UNC79 EMSY RCOR2 | 1.13e-05 | 963 | 94 | 12 | 28671696 | |
| Pubmed | 1.26e-05 | 17 | 94 | 3 | 20808911 | ||
| Pubmed | 1.51e-05 | 18 | 94 | 3 | 9858769 | ||
| Pubmed | 1.85e-05 | 119 | 94 | 5 | 23508102 | ||
| Pubmed | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. | 1.87e-05 | 419 | 94 | 8 | 27107012 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FSIP2 TBC1D10B LATS1 AKAP9 RAPH1 TCERG1 PPP1R12A SEC24B EIF4G3 CIC DCP1A | 2.14e-05 | 861 | 94 | 11 | 36931259 |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 10909971 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 2.16e-05 | 3 | 94 | 2 | 18163520 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 15105429 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17082618 | ||
| Pubmed | A role for ATF2 in regulating MITF and melanoma development. | 2.16e-05 | 3 | 94 | 2 | 21203491 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 36635261 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 35175239 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21486700 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23382855 | ||
| Pubmed | CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells. | 2.16e-05 | 3 | 94 | 2 | 33786634 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.18e-05 | 123 | 94 | 5 | 26912792 | |
| Pubmed | 2.26e-05 | 124 | 94 | 5 | 20850016 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.41e-05 | 332 | 94 | 7 | 32786267 | |
| Pubmed | 3.57e-05 | 68 | 94 | 4 | 22779921 | ||
| Pubmed | 3.89e-05 | 339 | 94 | 7 | 30415952 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | TPR YEATS2 COL18A1 EIF2D RBBP6 ATF7IP PPP1R12A SEC24B DDX28 WAC DCP1A | 3.99e-05 | 922 | 94 | 11 | 27609421 |
| Pubmed | 4.22e-05 | 233 | 94 | 6 | 29518331 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 8798441 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 12391146 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 24613343 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 18719024 | ||
| Interaction | FEV interactions | RLF SP2 KMT2C ZNF609 TAF9B ZNF608 VEZF1 CTCF ARID2 POU2F1 ASXL2 POGZ RREB1 CREB1 CIC EMSY | 1.19e-15 | 203 | 93 | 16 | int:FEV |
| Interaction | HNF4A interactions | TRIM33 YEATS2 KMT2C ZNF609 KAT5 TAF9B ZNF608 ATF7IP ARID2 ASXL2 POGZ RREB1 CIC EMSY | 3.16e-11 | 275 | 93 | 14 | int:HNF4A |
| Interaction | SP7 interactions | TRIM33 KMT2C ZNF609 ZNF608 TCERG1 RBBP6 ARID2 MITF POU2F1 PROSER1 POGZ MEF2A CIC FILIP1L | 1.19e-10 | 304 | 93 | 14 | int:SP7 |
| Interaction | KLF8 interactions | RLF TRIM33 YEATS2 ZNF609 KAT5 TAF9B CTCF ATF7IP ARID2 POU2F1 POGZ RREB1 CIC EMSY | 3.37e-10 | 329 | 93 | 14 | int:KLF8 |
| Interaction | SMC5 interactions | TPR TRIM33 YEATS2 ZNF609 TAF9B TCERG1 VEZF1 SNAP91 CTCF RBBP6 ATF7IP ARID2 MDC1 SAP30BP SYT1 U2AF2 POGZ RREB1 CREB1 CIC EMSY WAC | 6.71e-10 | 1000 | 93 | 22 | int:SMC5 |
| Interaction | CBX3 interactions | RLF TRIM33 YEATS2 TAF9B VEZF1 RBBP6 ATF7IP ARID2 PPP1R12A CHD5 MDC1 HIPK2 BRD3 ASXL2 POGZ RREB1 CIC WAC | 7.81e-10 | 646 | 93 | 18 | int:CBX3 |
| Interaction | CRX interactions | RLF TRIM33 KMT2C ZNF609 KAT5 ZNF608 ARID2 POU2F1 PROSER1 ASXL2 POGZ RREB1 | 2.09e-09 | 254 | 93 | 12 | int:CRX |
| Interaction | ELF4 interactions | 3.01e-09 | 115 | 93 | 9 | int:ELF4 | |
| Interaction | AR interactions | TPR TRIM33 KMT2C ZNF609 KAT5 TAF9B ZNF608 ARID2 FOSL2 MDC1 HIPK2 U2AF2 POU2F1 BRD3 RREB1 CREB1 ATF2 MEF2A CIC EMSY WAC | 3.51e-09 | 992 | 93 | 21 | int:AR |
| Interaction | EGR2 interactions | TRIM33 KMT2C ZNF609 ZNF608 ARID2 MITF PROSER1 POGZ RREB1 EMSY | 6.54e-09 | 171 | 93 | 10 | int:EGR2 |
| Interaction | ERG interactions | TRIM33 KMT2C ZNF609 ZNF608 ATF7IP MITF HIPK2 BRD3 ASXL2 CIC EMSY | 6.55e-09 | 223 | 93 | 11 | int:ERG |
| Interaction | CEBPA interactions | RLF TRIM33 YEATS2 KMT2C ZNF609 KAT5 AKAP9 TCERG1 VEZF1 ZNF652 ARID2 FOSL2 POU2F1 BIN2 ASXL2 POGZ RREB1 CREB1 ATF2 MEF2A CIC EMSY WAC | 7.26e-09 | 1245 | 93 | 23 | int:CEBPA |
| Interaction | NFIX interactions | RLF KMT2C ZNF609 ZNF608 ARID2 POU2F1 POGZ RREB1 CREB1 CIC EMSY | 7.88e-09 | 227 | 93 | 11 | int:NFIX |
| Interaction | TEAD1 interactions | 8.63e-09 | 176 | 93 | 10 | int:TEAD1 | |
| Interaction | PAX6 interactions | RLF KMT2C ZNF609 ZNF608 CTCF ARID2 MITF HIPK2 POU2F1 ASXL2 POGZ RREB1 CIC | 1.32e-08 | 366 | 93 | 13 | int:PAX6 |
| Interaction | HNF1B interactions | KMT2C ZNF609 ZNF608 ATF7IP ARID2 PROSER1 ASXL2 POGZ CREB1 CIC | 1.80e-08 | 190 | 93 | 10 | int:HNF1B |
| Interaction | NUP43 interactions | RLF FSIP2 YEATS2 ZNF609 TAF9B ZNF608 CTCF RBBP6 ATF7IP ARID2 PPP1R12A MDC1 ASXL2 POGZ EIF4G3 EMSY | 2.52e-08 | 625 | 93 | 16 | int:NUP43 |
| Interaction | TERF2IP interactions | TRIM33 YEATS2 ZNF609 TAF9B ZNF608 TCERG1 CTCF RBBP6 ATF7IP MDC1 SAP30BP POGZ RREB1 CIC EMSY | 3.31e-08 | 552 | 93 | 15 | int:TERF2IP |
| Interaction | POU5F1 interactions | TPR TRIM33 YEATS2 COL18A1 TCERG1 CHD5 MDC1 SAP30BP MITF BRD3 CREB1 ATF2 EMSY DDX28 RCOR2 | 6.92e-08 | 584 | 93 | 15 | int:POU5F1 |
| Interaction | KLF3 interactions | 1.00e-07 | 228 | 93 | 10 | int:KLF3 | |
| Interaction | HDAC1 interactions | RLF TPR YEATS2 ZNF609 KAT5 AKAP9 ZNF608 RAPH1 CTCF CHD5 U2AF2 POU2F1 RREB1 ANKHD1 CREB1 MEF2A CIC EMSY RCOR2 DCP1A | 1.23e-07 | 1108 | 93 | 20 | int:HDAC1 |
| Interaction | YY1 interactions | YEATS2 KAT5 TAF9B CTCF ATF7IP ARID2 MDC1 ASXL2 POGZ CREB1 ATF2 CIC EMSY | 1.64e-07 | 454 | 93 | 13 | int:YY1 |
| Interaction | SNRNP40 interactions | YEATS2 ZNF609 TAF9B ZNF608 TCERG1 VEZF1 CTCF RBBP6 ARID2 MDC1 U2AF2 POGZ EMSY WAC PAPOLG | 2.13e-07 | 637 | 93 | 15 | int:SNRNP40 |
| Interaction | FHL2 interactions | YEATS2 SP2 KAT5 SOX30 SAP30BP MITF HIPK2 ASXL2 POGZ CREB1 EMSY DCP1A | 2.79e-07 | 396 | 93 | 12 | int:FHL2 |
| Interaction | ATF7 interactions | 4.51e-07 | 63 | 93 | 6 | int:ATF7 | |
| Interaction | ZMYM2 interactions | 4.96e-07 | 271 | 93 | 10 | int:ZMYM2 | |
| Interaction | NFIC interactions | 5.51e-07 | 210 | 93 | 9 | int:NFIC | |
| Interaction | SOX5 interactions | 8.36e-07 | 162 | 93 | 8 | int:SOX5 | |
| Interaction | KLF15 interactions | 9.20e-07 | 290 | 93 | 10 | int:KLF15 | |
| Interaction | TBR1 interactions | 9.20e-07 | 113 | 93 | 7 | int:TBR1 | |
| Interaction | PML interactions | TRIM33 YEATS2 SP2 ZNF609 KAT5 KLF10 ZNF608 TCERG1 ATF7IP MDC1 SEC24B MITF HIPK2 ATF2 EMSY DCP1A PAPOLG | 1.11e-06 | 933 | 93 | 17 | int:PML |
| Interaction | ELK3 interactions | 1.38e-06 | 120 | 93 | 7 | int:ELK3 | |
| Interaction | SOX2 interactions | RLF TRIM33 SP2 KMT2C ZNF609 ZNF608 CTCF ARID2 PPP1R12A MITF POU2F1 PROSER1 POGZ EIF4G3 ANKHD1 CPLANE1 CREB1 MEF2A CIC DDX28 RCOR2 | 1.54e-06 | 1422 | 93 | 21 | int:SOX2 |
| Interaction | NAA40 interactions | TPR YEATS2 RAPH1 TCERG1 CTCF RBBP6 ATF7IP ARID2 PPP1R12A SEC24B SAP30BP EIF4G3 ANKHD1 CIC EMSY WAC DCP1A | 2.12e-06 | 978 | 93 | 17 | int:NAA40 |
| Interaction | SOX7 interactions | 2.17e-06 | 82 | 93 | 6 | int:SOX7 | |
| Interaction | PAX2 interactions | 2.68e-06 | 85 | 93 | 6 | int:PAX2 | |
| Interaction | MYB interactions | 2.75e-06 | 133 | 93 | 7 | int:MYB | |
| Interaction | BRD3 interactions | TBC1D10B TAF9B TCERG1 CTCF SPP1 RBBP6 MDC1 SAP30BP U2AF2 BRD3 POGZ TAF4B | 2.84e-06 | 494 | 93 | 12 | int:BRD3 |
| Interaction | SUMO2 interactions | TPR TRIM33 TCERG1 ATF7IP ARID2 MDC1 HIPK2 U2AF2 BRD3 POGZ RREB1 CIC RCOR2 | 3.15e-06 | 591 | 93 | 13 | int:SUMO2 |
| Interaction | WWTR1 interactions | YEATS2 LATS1 RAPH1 TCERG1 ARID2 PPP1R12A SEC24B POGZ ANKHD1 EMSY RCOR2 | 3.89e-06 | 422 | 93 | 11 | int:WWTR1 |
| Interaction | SOX10 interactions | 4.25e-06 | 92 | 93 | 6 | int:SOX10 | |
| Interaction | SOX17 interactions | 5.12e-06 | 95 | 93 | 6 | int:SOX17 | |
| Interaction | H3-4 interactions | KMT2C USF3 KAT5 TAF9B CHD5 POGZ TAF4B RREB1 CREB1 MEF2A EMSY | 6.86e-06 | 448 | 93 | 11 | int:H3-4 |
| Interaction | PRR20E interactions | 7.31e-06 | 101 | 93 | 6 | int:PRR20E | |
| Interaction | TLX3 interactions | 8.03e-06 | 291 | 93 | 9 | int:TLX3 | |
| Interaction | H3-3A interactions | RLF KMT2C VEZF1 ARID2 CHD5 MDC1 U2AF2 POU2F1 BRD3 POGZ RREB1 CIC EMSY PAPOLG | 8.30e-06 | 749 | 93 | 14 | int:H3-3A |
| Interaction | NFYA interactions | 9.15e-06 | 105 | 93 | 6 | int:NFYA | |
| Interaction | TLE3 interactions | 9.26e-06 | 376 | 93 | 10 | int:TLE3 | |
| Interaction | UBE2I interactions | TRIM33 LATS1 KAT5 TCERG1 VEZF1 RBBP6 ATF7IP MITF HIPK2 POU2F1 CREB1 ATF2 MEF2A | 9.39e-06 | 654 | 93 | 13 | int:UBE2I |
| Interaction | EN1 interactions | 1.19e-05 | 110 | 93 | 6 | int:EN1 | |
| Interaction | VSX1 interactions | 1.34e-05 | 66 | 93 | 5 | int:VSX1 | |
| Interaction | FOS interactions | 1.40e-05 | 312 | 93 | 9 | int:FOS | |
| Interaction | TLX1 interactions | 1.67e-05 | 175 | 93 | 7 | int:TLX1 | |
| Interaction | H3C3 interactions | 1.74e-05 | 495 | 93 | 11 | int:H3C3 | |
| Interaction | NFYC interactions | 1.80e-05 | 177 | 93 | 7 | int:NFYC | |
| Interaction | H2AC4 interactions | KMT2C TBC1D10B USF3 KAT5 CTCF ARID2 U2AF2 POU2F1 POGZ ANKHD1 UNC79 | 2.14e-05 | 506 | 93 | 11 | int:H2AC4 |
| Interaction | LHX2 interactions | 2.23e-05 | 183 | 93 | 7 | int:LHX2 | |
| Interaction | PAX7 interactions | 2.37e-05 | 124 | 93 | 6 | int:PAX7 | |
| Interaction | PHF20L1 interactions | 2.51e-05 | 75 | 93 | 5 | int:PHF20L1 | |
| Interaction | KDM1A interactions | RLF TPR YEATS2 ZNF609 AKAP9 ZNF608 RAPH1 ATF7IP PPP1R12A POGZ RREB1 ANKHD1 CIC RCOR2 DCP1A | 2.52e-05 | 941 | 93 | 15 | int:KDM1A |
| Interaction | BAG2 interactions | TRIM33 YEATS2 ZNF609 PPP1R12A CHD5 MDC1 POU2F1 BRD3 RREB1 EIF4G3 ANKHD1 CIC | 2.86e-05 | 622 | 93 | 12 | int:BAG2 |
| Interaction | DYNLL2 interactions | 2.96e-05 | 263 | 93 | 8 | int:DYNLL2 | |
| Interaction | POGZ interactions | 3.12e-05 | 265 | 93 | 8 | int:POGZ | |
| Interaction | CHD8 interactions | 3.13e-05 | 193 | 93 | 7 | int:CHD8 | |
| Interaction | MYOD1 interactions | 3.24e-05 | 194 | 93 | 7 | int:MYOD1 | |
| Interaction | HNF1A interactions | 3.43e-05 | 80 | 93 | 5 | int:HNF1A | |
| Interaction | IRF4 interactions | 4.60e-05 | 85 | 93 | 5 | int:IRF4 | |
| Interaction | SOX15 interactions | 4.88e-05 | 141 | 93 | 6 | int:SOX15 | |
| Interaction | GSC interactions | 5.15e-05 | 87 | 93 | 5 | int:GSC | |
| Interaction | TCERG1L interactions | 6.30e-05 | 3 | 93 | 2 | int:TCERG1L | |
| Interaction | FOXI1 interactions | 6.73e-05 | 92 | 93 | 5 | int:FOXI1 | |
| Interaction | MEN1 interactions | KMT2C ZNF609 ZNF608 TCERG1 CTCF RBBP6 ARID2 FOSL2 MDC1 U2AF2 POGZ ATF2 EMSY WAC DCP1A | 7.00e-05 | 1029 | 93 | 15 | int:MEN1 |
| Interaction | KLF9 interactions | 7.08e-05 | 93 | 93 | 5 | int:KLF9 | |
| Interaction | DUXB interactions | 7.38e-05 | 18 | 93 | 3 | int:DUXB | |
| Interaction | TFAP4 interactions | 7.68e-05 | 153 | 93 | 6 | int:TFAP4 | |
| Interaction | KLF6 interactions | 7.84e-05 | 95 | 93 | 5 | int:KLF6 | |
| Interaction | TAF8 interactions | 8.32e-05 | 50 | 93 | 4 | int:TAF8 | |
| Interaction | SOX9 interactions | 8.66e-05 | 97 | 93 | 5 | int:SOX9 | |
| Interaction | LHX8 interactions | 1.05e-04 | 53 | 93 | 4 | int:LHX8 | |
| Interaction | PHF20 interactions | 1.05e-04 | 53 | 93 | 4 | int:PHF20 | |
| Interaction | CTBP1 interactions | 1.08e-04 | 406 | 93 | 9 | int:CTBP1 | |
| Interaction | SMG7 interactions | 1.14e-04 | 319 | 93 | 8 | int:SMG7 | |
| Interaction | LHX4 interactions | 1.20e-04 | 166 | 93 | 6 | int:LHX4 | |
| Interaction | SETD1A interactions | 1.37e-04 | 170 | 93 | 6 | int:SETD1A | |
| Interaction | HMGA1 interactions | 1.37e-04 | 419 | 93 | 9 | int:HMGA1 | |
| Interaction | YAP1 interactions | TPR COL18A1 KMT2C LATS1 TAF9B TCERG1 RBBP6 ARID2 PPP1R12A MDC1 SAP30BP POGZ CREB1 RCOR2 DCP1A | 1.40e-04 | 1095 | 93 | 15 | int:YAP1 |
| Interaction | KDM1B interactions | 1.49e-04 | 58 | 93 | 4 | int:KDM1B | |
| Interaction | MRGBP interactions | 1.50e-04 | 109 | 93 | 5 | int:MRGBP | |
| Interaction | PRR20A interactions | 1.50e-04 | 109 | 93 | 5 | int:PRR20A | |
| Interaction | PIAS4 interactions | 1.51e-04 | 173 | 93 | 6 | int:PIAS4 | |
| Interaction | ASF1A interactions | 1.55e-04 | 249 | 93 | 7 | int:ASF1A | |
| Interaction | PHF12 interactions | 1.57e-04 | 110 | 93 | 5 | int:PHF12 | |
| Interaction | PAX8 interactions | 1.64e-04 | 111 | 93 | 5 | int:PAX8 | |
| Interaction | MAD2L1 interactions | 1.67e-04 | 252 | 93 | 7 | int:MAD2L1 | |
| Interaction | TBP interactions | 1.71e-04 | 253 | 93 | 7 | int:TBP | |
| Interaction | CREB1 interactions | 1.75e-04 | 254 | 93 | 7 | int:CREB1 | |
| Interaction | PHF21A interactions | 1.88e-04 | 343 | 93 | 8 | int:PHF21A | |
| Interaction | TBXT interactions | 2.01e-04 | 116 | 93 | 5 | int:TBXT | |
| Interaction | LHX3 interactions | 2.17e-04 | 185 | 93 | 6 | int:LHX3 | |
| Interaction | RNF4 interactions | RLF YEATS2 TBC1D10B ZNF609 ZNF608 VEZF1 CTCF RBBP6 ATF7IP ZNF652 MDC1 NFASC KIRREL1 POGZ CREB1 ATF2 WAC | 2.27e-04 | 1412 | 93 | 17 | int:RNF4 |
| Cytoband | 5q31 | 1.74e-03 | 115 | 94 | 3 | 5q31 | |
| GeneFamily | CD molecules|Mucins | 4.43e-05 | 21 | 60 | 3 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.14e-04 | 718 | 60 | 10 | 28 | |
| GeneFamily | Basic leucine zipper proteins | 5.74e-04 | 49 | 60 | 3 | 506 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.11e-03 | 15 | 60 | 2 | 26 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.00e-03 | 161 | 60 | 4 | 593 | |
| GeneFamily | PHD finger proteins | 3.33e-03 | 90 | 60 | 3 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.35e-03 | 36 | 60 | 2 | 823 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR TRIM33 KMT2C ZNF609 LATS1 AKAP9 VEZF1 CTCF RBBP6 ATF7IP ZNF652 ARID2 PPP1R12A BIN2 ASXL2 CREB1 ATF2 WAC DCP1A PAPOLG | 2.20e-07 | 1492 | 93 | 20 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L FSIP2 AKAP9 RAPH1 TCERG1 SNAP91 PCLO VCAN CHD5 SYT1 NFASC POU2F1 BSN SPAG17 MDGA1 UNC79 RCOR2 | 3.15e-07 | 1106 | 93 | 17 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L RLF TRIM33 AKAP9 KLF10 VEZF1 CTCF PPP1R12A SEC24B MITF EIF4G3 CREB1 ATF2 MEF2A FILIP1L | 3.31e-07 | 856 | 93 | 15 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SECISBP2L RLF TRIM33 SP2 AKAP9 KLF10 ATF7IP FOSL2 SEC24B POU2F1 ATF2 MEF2A WAC DCP1A | 1.19e-06 | 822 | 93 | 14 | M6782 |
| Coexpression | GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP | 6.46e-06 | 196 | 93 | 7 | M3239 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 1.50e-05 | 223 | 93 | 7 | M17621 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 1.81e-05 | 44 | 93 | 4 | M2377 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 1.98e-05 | 45 | 93 | 4 | MM929 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | AKAP9 SNAP91 PCLO CHD5 SCN7A SYT1 NFASC KIRREL1 BSN MDGA1 UNC79 | 3.96e-05 | 703 | 93 | 11 | M39070 |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 4.10e-05 | 54 | 93 | 4 | M15468 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIM33 AKAP9 KLF10 PPP1R12A SEC24B EIF4G3 CREB1 ATF2 FILIP1L | 4.22e-05 | 466 | 93 | 9 | M13522 |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 6.52e-05 | 281 | 93 | 7 | M7089 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH2_UP | 6.99e-05 | 195 | 93 | 6 | M5424 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN | 7.19e-05 | 196 | 93 | 6 | M4990 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 7.43e-05 | 389 | 93 | 8 | M39102 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 7.61e-05 | 198 | 93 | 6 | M7610 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | 7.82e-05 | 199 | 93 | 6 | M7784 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 7.82e-05 | 199 | 93 | 6 | M3217 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 7.82e-05 | 199 | 93 | 6 | M3417 | |
| Coexpression | GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN | 8.04e-05 | 200 | 93 | 6 | M5834 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN | 8.04e-05 | 200 | 93 | 6 | M9049 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 8.04e-05 | 200 | 93 | 6 | M5566 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 8.04e-05 | 200 | 93 | 6 | M4979 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP | 8.04e-05 | 200 | 93 | 6 | M3838 | |
| Coexpression | TURJANSKI_MAPK11_TARGETS | 1.24e-04 | 5 | 93 | 2 | M2492 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | KMT2C USF3 KLF10 RAPH1 SNAP91 ZNF652 PCLO NFASC IGSF1 EIF4G3 UNC79 WAC | 1.29e-04 | 946 | 93 | 12 | M39169 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SECISBP2L LATS1 MANSC1 AKAP9 SPP1 ATF7IP ZNF652 ARID2 HIPK2 POGZ PAPOLG | 1.35e-04 | 807 | 93 | 11 | M16651 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.84e-06 | 291 | 92 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.79e-05 | 261 | 92 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | USF3 LATS1 AKAP9 RBBP6 HIPK2 POU2F1 POGZ ANKHD1 CPLANE1 ATF2 EMSY WAC PAPOLG | 3.08e-05 | 780 | 92 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | TPR MANSC1 AKAP9 KLF10 RAPH1 TCERG1 FOSL2 PPP1R12A HIPK2 ASXL2 FLVCR2 CPLANE1 DCP1A | 3.25e-05 | 784 | 92 | 13 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.49e-05 | 209 | 92 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.59e-05 | 469 | 92 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RLF TPR LATS1 AKAP9 TBC1D30 RBBP6 PPP1R12A VCAN PCDHB12 PCDHB11 ASXL2 CPLANE1 DCP1A | 4.32e-05 | 806 | 92 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.68e-05 | 149 | 92 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | RLF LATS1 AKAP9 SNAP91 RBBP6 PPP1R12A VCAN PCDHB12 PCDHB11 SYT1 ASXL2 CPLANE1 ATF2 | 5.02e-05 | 818 | 92 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR SP2 ZNF609 AKAP9 TAF9B VEZF1 SNAP91 CTCF HIPK2 ZC3H12B POGZ CPLANE1 MDGA1 EMSY RCOR2 WAC PAPOLG | 7.32e-05 | 1370 | 92 | 17 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 7.72e-05 | 163 | 92 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | LATS1 SNAP91 RBBP6 PPP1R12A VCAN PCDHB12 PCDHB11 ASXL2 CPLANE1 | 9.84e-05 | 427 | 92 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.07e-04 | 173 | 92 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR TRIM33 RAPH1 ARID2 PPP1R12A MDC1 SEC24B POU2F1 ASXL2 WAC | 1.65e-04 | 564 | 92 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.02e-04 | 369 | 92 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.25e-04 | 375 | 92 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.68e-04 | 385 | 92 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | USF3 LATS1 AKAP9 TAF9B PCLO SAP30BP HIPK2 POU2F1 CPLANE1 CIC EMSY WAC FILIP1L | 3.17e-04 | 985 | 92 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 3.68e-04 | 78 | 92 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.09e-04 | 311 | 92 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.17e-04 | 312 | 92 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | COL18A1 AKAP9 SPP1 ARID2 FOSL2 PPP1R12A VCAN HIPK2 ASXL2 CPLANE1 DCP1A | 5.85e-04 | 786 | 92 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 5.90e-04 | 156 | 92 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.82e-04 | 339 | 92 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 6.92e-04 | 40 | 92 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.53e-09 | 186 | 93 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.39e-09 | 193 | 93 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.02e-07 | 135 | 93 | 6 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.02e-07 | 135 | 93 | 6 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 179 | 93 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-06 | 186 | 93 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-06 | 196 | 93 | 6 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-06 | 196 | 93 | 6 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-06 | 197 | 93 | 6 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.96e-06 | 200 | 93 | 6 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-05 | 148 | 93 | 5 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.57e-05 | 166 | 93 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.80e-05 | 169 | 93 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 2.97e-05 | 171 | 93 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 177 | 93 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.99e-05 | 182 | 93 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 182 | 93 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 182 | 93 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-05 | 182 | 93 | 5 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-05 | 182 | 93 | 5 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.10e-05 | 183 | 93 | 5 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 184 | 93 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-05 | 184 | 93 | 5 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.43e-05 | 186 | 93 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 186 | 93 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.43e-05 | 186 | 93 | 5 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.54e-05 | 187 | 93 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.66e-05 | 188 | 93 | 5 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-05 | 188 | 93 | 5 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 188 | 93 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.78e-05 | 189 | 93 | 5 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-05 | 191 | 93 | 5 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-05 | 191 | 93 | 5 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 5.02e-05 | 191 | 93 | 5 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.15e-05 | 192 | 93 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 193 | 93 | 5 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.28e-05 | 193 | 93 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 5.28e-05 | 193 | 93 | 5 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.41e-05 | 194 | 93 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 5.41e-05 | 194 | 93 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-05 | 195 | 93 | 5 | bbafea2262074beede78e286276a1927ecb80582 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-05 | 195 | 93 | 5 | 145c50fa60d9df162152be0a6c070213ebdb8119 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-05 | 196 | 93 | 5 | 92c5be6e43571730c7709046856f6c8ae341a4a1 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.68e-05 | 196 | 93 | 5 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 196 | 93 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Control-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class | 5.68e-05 | 196 | 93 | 5 | e2c2a30fa3ee3034fbde5335be169e880dde622d | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.68e-05 | 196 | 93 | 5 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-05 | 196 | 93 | 5 | 0e7ea6e66bfbb0006ee9651714fe48b0ee194290 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 197 | 93 | 5 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.82e-05 | 197 | 93 | 5 | 1bf69db7e830315c8fa85e6e85b0cb94014e9169 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 197 | 93 | 5 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | 9430ce7016b1a4724de036aab3e3e4082d24e436 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-05 | 198 | 93 | 5 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.96e-05 | 198 | 93 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.10e-05 | 199 | 93 | 5 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.10e-05 | 199 | 93 | 5 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.10e-05 | 199 | 93 | 5 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 93 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-05 | 200 | 93 | 5 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-05 | 200 | 93 | 5 | c30da72c3581d384b76c95f5989e32a36d783ef3 | |
| ToppCell | BL-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.25e-05 | 200 | 93 | 5 | dc3d5af1d4b15cc258d456f9f450550874456299 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefh_(Cerebellum_basket_cells_1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 47 | 93 | 3 | 59811807a4b5baec55505bb4c38ac684b0a49c9a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefh_(Cerebellum_basket_cells_1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 47 | 93 | 3 | 74ed0dc55bcfe6e5f7bab42ee060692d51a39e5a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-04 | 131 | 93 | 4 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.69e-04 | 132 | 93 | 4 | 9633653dba1edee47d915212fb6e68426da49de5 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.84e-04 | 135 | 93 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.55e-04 | 147 | 93 | 4 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 155 | 93 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.19e-04 | 156 | 93 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-04 | 159 | 93 | 4 | 210ac7fa89514a84f38d9f42254e38fbc2bc5f42 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.52e-04 | 160 | 93 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 161 | 93 | 4 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.60e-04 | 161 | 93 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.69e-04 | 162 | 93 | 4 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.32e-04 | 169 | 93 | 4 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.32e-04 | 169 | 93 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 4.41e-04 | 71 | 93 | 3 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 4.52e-04 | 171 | 93 | 4 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-04 | 171 | 93 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-04 | 171 | 93 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-04 | 172 | 93 | 4 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.72e-04 | 173 | 93 | 4 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 173 | 93 | 4 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.72e-04 | 173 | 93 | 4 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-04 | 175 | 93 | 4 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.93e-04 | 175 | 93 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.93e-04 | 175 | 93 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-04 | 176 | 93 | 4 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.04e-04 | 176 | 93 | 4 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-04 | 176 | 93 | 4 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-04 | 176 | 93 | 4 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.04e-04 | 176 | 93 | 4 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.13e-08 | 160 | 94 | 9 | 4404_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.64e-08 | 164 | 94 | 9 | 3852_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.93e-08 | 166 | 94 | 9 | 5324_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.09e-08 | 167 | 94 | 9 | 6047_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | TRIM33 YEATS2 ZNF609 AKAP9 ATF7IP PPP1R12A SEC24B POU2F1 RREB1 | 3.79e-08 | 171 | 94 | 9 | 7535_DN |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.40e-08 | 174 | 94 | 9 | 1276_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.48e-08 | 182 | 94 | 9 | 3887_DN | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 4.02e-07 | 164 | 94 | 8 | 3963_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.21e-07 | 165 | 94 | 8 | 3851_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.52e-07 | 171 | 94 | 8 | 5026_UP | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.49e-07 | 178 | 94 | 8 | 3998_DN | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.55e-06 | 160 | 94 | 7 | 5275_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 6.03e-06 | 167 | 94 | 7 | 5640_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.03e-06 | 167 | 94 | 7 | 4801_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 6.78e-06 | 170 | 94 | 7 | 3945_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 7.90e-06 | 174 | 94 | 7 | 6048_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.85e-06 | 180 | 94 | 7 | 4541_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.10e-05 | 183 | 94 | 7 | 7498_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.14e-05 | 184 | 94 | 7 | 2321_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HG-U133A | 1.71e-05 | 196 | 94 | 7 | 1906_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 6818_DN | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.74e-05 | 162 | 94 | 6 | 7340_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 6.58e-05 | 166 | 94 | 6 | 2525_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 7.26e-05 | 169 | 94 | 6 | 2193_UP | |
| Drug | AC1NSN3X | 7.36e-05 | 54 | 94 | 4 | CID005366189 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 8.53e-05 | 174 | 94 | 6 | 7530_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 9.97e-05 | 179 | 94 | 6 | 2656_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 180 | 94 | 6 | 3397_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 182 | 94 | 6 | 3630_DN | |
| Drug | staurosporine; Down 200; 0.1uM; MCF7; HG-U133A | 1.16e-04 | 184 | 94 | 6 | 423_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.27e-04 | 187 | 94 | 6 | 7080_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.30e-04 | 188 | 94 | 6 | 6735_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.30e-04 | 188 | 94 | 6 | 3325_DN | |
| Drug | phosphine | 1.30e-04 | 118 | 94 | 5 | CID000024404 | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.34e-04 | 189 | 94 | 6 | 1288_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.38e-04 | 190 | 94 | 6 | 4507_DN | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 3139_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 7008_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 1873_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 2209_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 4727_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A | 1.59e-04 | 195 | 94 | 6 | 1981_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 3568_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5811_DN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5874_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2915_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; HL60; HG-U133A | 1.68e-04 | 197 | 94 | 6 | 1395_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4286_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 2839_DN | |
| Drug | tamibarotene | 1.76e-04 | 596 | 94 | 10 | ctd:C061133 | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 4316_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 7140_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; HL60; HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1763_DN | |
| Disease | Intellectual Disability | 1.01e-05 | 447 | 91 | 9 | C3714756 | |
| Disease | C-reactive protein measurement | YEATS2 LATS1 KAT5 KLF10 ZNF608 HLA-DRA LPA FOSL2 BRD3 TAF4B BSN RREB1 EIF4G3 | 8.26e-05 | 1206 | 91 | 13 | EFO_0004458 |
| Disease | Pick's disease (is_marker_for) | 1.96e-04 | 7 | 91 | 2 | DOID:11870 (is_marker_for) | |
| Disease | serum IgG measurement, response to dietary antigen | 5.08e-04 | 11 | 91 | 2 | EFO_0004565, EFO_0005844 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 9.86e-04 | 63 | 91 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 9.86e-04 | 63 | 91 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.03e-03 | 64 | 91 | 3 | EFO_0022253 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.63e-03 | 75 | 91 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Hodgkins lymphoma | 2.11e-03 | 82 | 91 | 3 | EFO_0000183 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.43e-03 | 301 | 91 | 5 | DOID:684 (is_marker_for) | |
| Disease | stomach carcinoma (is_marker_for) | 2.48e-03 | 24 | 91 | 2 | DOID:5517 (is_marker_for) | |
| Disease | erosive tooth wear measurement | 2.75e-03 | 90 | 91 | 3 | EFO_0009331 | |
| Disease | Heart valve disease | 2.91e-03 | 26 | 91 | 2 | C0018824 | |
| Disease | blood rubidium measurement | 2.91e-03 | 26 | 91 | 2 | EFO_0021529 | |
| Disease | Neurodevelopmental Disorders | 3.01e-03 | 93 | 91 | 3 | C1535926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPPTVSQTPVIAATP | 186 | Q15059 | |
| SQTPVIAATPVPTIT | 191 | Q15059 | |
| IAATPVPTITANVTS | 196 | Q15059 | |
| VPTITANVTSVPVPP | 201 | Q15059 | |
| SESTVPPSLPVDSVV | 1376 | Q99996 | |
| RITSFVIPEPSPTSQ | 351 | P41214 | |
| VTVSSSVVPVLPSAV | 2016 | P13611 | |
| VQVPVPVTVPVATTS | 116 | P49711 | |
| AVETVTISPPLAVSP | 216 | Q8TDI0 | |
| PLDQTASTTIVIVPT | 1066 | Q8IZF6 | |
| PQQRPSVVVSPHSTT | 1461 | Q68CP9 | |
| TVITQAPSSNRPIVP | 196 | P15336 | |
| PETSVPVVTPTASTA | 501 | O60641 | |
| VISPPVRTATVSSPL | 261 | Q9UBW5 | |
| PEITTPVLITPASIT | 286 | Q9NPI6 | |
| ASVPVAVTPSPLTSL | 876 | Q76L83 | |
| TAEAVSPTPIPTVTA | 26 | Q13434 | |
| QITSVSTSVPRSVPP | 421 | Q8IZ40 | |
| PLVTIPAPTSTKTVA | 781 | Q70E73 | |
| PAPTSTKTVAPVVTQ | 786 | Q70E73 | |
| PATEVFTPVVPTVDT | 141 | P10451 | |
| VNISSETVPPTISVP | 431 | Q8NFP4 | |
| PRPSTQTDLFVTPVT | 2181 | Q8NEZ4 | |
| QRQTIVIPDTPSPTV | 871 | Q9H2X6 | |
| VIPDTPSPTVSVITI | 876 | Q9H2X6 | |
| TPETVVPTAPELQIS | 1321 | Q14676 | |
| PSATTVTAITPAPIQ | 481 | O95835 | |
| QIPVTVALPTPATTS | 1741 | Q5HYC2 | |
| VEVVSPATPVPSETA | 151 | Q92993 | |
| PIAATLPITTQPASV | 2201 | Q9UPA5 | |
| PRTPLDPVSTIVTQV | 4271 | Q5CZC0 | |
| SVVPPVTAVEIPISS | 2621 | Q9Y6V0 | |
| PTTVIPSSPTVQNTE | 856 | Q02505 | |
| PLPVQPTADTTTHVT | 51 | P39060 | |
| PEVVQPTTVQSSTIP | 146 | Q9NUL7 | |
| QPQLATTAPPVTTVT | 261 | Q9H8J5 | |
| ATQPLATPVVSVTTP | 306 | Q02078 | |
| SITSPIPENTPETVV | 351 | Q9Y5F1 | |
| PAPVPDITATVSISV | 406 | Q7Z6E9 | |
| TPTRTIAATPIQTLP | 251 | P14859 | |
| SITSPIPENTPETVV | 351 | Q9Y5F2 | |
| VIRTPSLPTAPVTSI | 336 | Q86XN7 | |
| TTEATTVPIIPTVAP | 1061 | O94856 | |
| TVPIIPTVAPTTIAT | 1066 | O94856 | |
| KTVSPPTVCTIPTVV | 596 | Q9BWT3 | |
| TAIPATTPTFPASVI | 1316 | Q6WRI0 | |
| PSSTSQRISVELPVP | 1321 | Q8N6C5 | |
| SRASITVPSTPIQPI | 2376 | Q9H799 | |
| ITITPTATPLPRQSQ | 1111 | Q4L180 | |
| VPATPVAPTESQTVL | 371 | Q5T0F9 | |
| LHTPIVVTSTPAVTP | 261 | P15408 | |
| PVTESSVLTTPTVAP | 1466 | P08519 | |
| SVLTTPTVAPVPSTE | 1471 | P08519 | |
| PITNVPPEVTVLTNS | 106 | P01903 | |
| TSAPAITTVTVPTPI | 146 | P16220 | |
| PSVSVHPSVSINPSV | 31 | Q9UPI3 | |
| PVNTVSSTNLVTPPA | 716 | Q6VMQ6 | |
| PTAPTTVNVTHRPVT | 1031 | Q6VMQ6 | |
| HPPTVTLSIEPQTVQ | 221 | Q96J84 | |
| ANNPVVTTVVPSTPP | 281 | Q13118 | |
| IPTINTIATVEPTPA | 131 | P07498 | |
| LVPTSVIASTTQKPP | 306 | Q7Z589 | |
| STPSPIPNTVAVTAV | 341 | Q7Z589 | |
| IPNTVAVTAVVSSTP | 346 | Q7Z589 | |
| PVEPVTSVTQPSELL | 336 | O95487 | |
| VPATIVVPSTTPALT | 81 | P20132 | |
| PHTPVIVPAAATTVS | 426 | O43432 | |
| IPVSITPVTSPEAST | 811 | Q685J3 | |
| VSTPLTSILVSTVPV | 2926 | Q685J3 | |
| IPVSTTPVAIPEAST | 3051 | Q685J3 | |
| PTIPVATTISVSVIT | 3916 | Q685J3 | |
| SYTPTPVTQKPVTTV | 156 | Q9H195 | |
| TSIVVTPETPTTQAP | 481 | Q9H195 | |
| TITITIVPASPTDPC | 686 | Q9H195 | |
| AAPPVTTVATVLPSN | 11 | P21579 | |
| TVPKPSSVQSVAVPT | 191 | Q92750 | |
| TTPTIATPQTVSVPN | 156 | Q9HBM6 | |
| SLPITVTTAQAPPQR | 1231 | O75445 | |
| ATTQPPVETTVPEIQ | 516 | O60279 | |
| PVVSVHNTTINPTSP | 631 | Q9UPN9 | |
| TVSVSQQPVSAPVPI | 41 | Q7Z3K3 | |
| PINIVQTPIPITTSV | 426 | Q93073 | |
| VSPRISTPQTNTVPI | 451 | Q9BTA9 | |
| VQSPSPVTLFQPSVS | 476 | O94993 | |
| QAPPPVTSVITTEVD | 411 | Q6Q759 | |
| NIPSALTPTVVPVIV | 1156 | Q6Q759 | |
| LTPTVVPVIVTVPQS | 1161 | Q6Q759 | |
| EVPIEPPSATTTTTI | 1501 | Q8IWZ3 | |
| SKIIQLTPVPVSTPS | 961 | Q96RK0 | |
| PTAFSPASTVQTVPV | 1186 | A4D1E1 | |
| TAPVNIAHPVTITSP | 471 | Q14119 | |
| PVSQTPAINVSVPTT | 91 | O75030 | |
| PAINVSVPTTLPSAT | 96 | O75030 | |
| TAIPPLIVAETTTVP | 1841 | Q13129 | |
| TVSVSTPAPTATPVQ | 316 | O14776 | |
| RTVVATSTPPPLINA | 516 | Q92766 | |
| STSQTVSTPAPVPVI | 646 | P12270 | |
| VSTPAPVPVIESTEA | 651 | P12270 | |
| PAPIQKSSTTTTPVQ | 181 | Q02086 | |
| TTPTQPLTPLHVVTQ | 816 | O15014 | |
| PVTTATSAPVTLVAP | 41 | Q4KMP7 | |
| QVTQPSATRTPALIP | 2086 | Q68DE3 | |
| PVTSILPSQVNSSPV | 666 | Q9Y2I9 | |
| IPVTTIAQPTILTTT | 261 | Q9UHR5 | |
| SVPSLVTALSVPTIP | 461 | Q5HYM0 | |
| SPPSTINQTPVTLQV | 346 | P26368 | |
| PPQLIAIPTATFTTT | 746 | Q9ULD9 | |
| LIPSPSVSETVPIAS | 826 | Q01118 | |
| PVLISSSNPSVITQP | 326 | Q8TEC5 | |
| SPATPVPSVVNTATT | 511 | Q9Y2D9 | |
| PTARAPTQTPTQTII | 1136 | Q9H4Z2 | |
| TVVSATSLVPTPNPI | 1011 | Q9ULM3 | |
| PSLRPQVSSINPTVT | 81 | Q9P2D8 | |
| PQTTLTPLQESPVIS | 651 | Q9P206 | |
| VPTAVTIPVAPTVVN | 626 | O14974 |